IL6 and COVID-19: Additionally, although multiple inflammatory pathways, such as interleukin-6 (IL-6), are implicated in myocardial injury in COVID-19, their effect on indices of cardiac function is unknown and a better understanding of the degree and determinants of myocardial function may improve risk stratification and lead to new therapeutic approaches (8–10).